Optithera

Committed to the Health & Wellbeing of Patients with Diabetes

PREDICTION FOR DIABETES COMPLICATIONS

OPTITHERA’s direct-to-consumer genetic health risk tests for type-2 diabetes complications are making Precision Medicine a reality.

HOW IT WORKS

Direct-To-Consumer Test

Test Awareness

Patient with type 2 diabetes becomes aware of OPTITHERA’s genetic test.

Order Test

Buccal Swab Collection | Buy here

Collect DNA Sample

Receive DNA sample kit by mail. Follow the simple instructions to collect buccal swab. Send the sample kit to OPTITHERA using the return envelope with instructions.

DNA Analyzed

We analyze 600 common genomic variants to determine your Polygenic Risk Score (PRS) related to diabetes complications along with information on your sex, ethnicity, current age and age at onset of diabetes.

Personalized Report

Your healthcare professional and you will receive a confidential, personalized report that explains your genetic health risk test results.
You should then discuss your results with your healthcare professional.
Depending on your personalized risk assessment, your healthcare professional will have several preventive measures to offer such as lifestyle modifications or early administration of medication to prevent or delay the onset of diabetes-related complications.

Your data is confidential

DIABETES PATIENTS & FAMILIES

Pavel Hamet,

Founding President of OPTITHERA

CM, OQ, MD, PhD, FRCPC, FAHA, FRSM, FCAHS

Canada Research Chair in Predictive Genomics

Professor of Medicine, University of Montréal

OPTITHERA is a Precision Medicine company focused on the discovery and clinical application of genomic signatures predictive of susceptibility to complications and optimized therapeutic responsiveness of patients with diabetes.

Meet our team